Balter James M, Brock Kristy K, Lam Kwok L, Tatro Daniel, Dawson Laura A, McShan Daniel L, Ten Haken Randall K
Department of Radiation Oncology, University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, MI 48109, USA.
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):610-4. doi: 10.1016/j.ijrobp.2005.05.014.
A mechanism has been developed to evaluate the influence of random setup variations on dose during treatment planning. The information available for studying these factors shifts from population-based models toward patient-specific data as treatment progresses and setup measurements for an individual patient become available. This study evaluates the influence of population as well as patient-specific setup distributions on treatment plans for focal liver tumors.
Eight patients with focal liver tumors were treated on a protocol that involved online setup measurement and adjustment, as well as ventilatory immobilization. Summary statistics from these three-dimensional conformal treatments yielded individual and population distributions of position at initial setup for each fraction. A convolution model for evaluation of the influence of random setup variation on calculated dose distributions has been previously described and investigated for application to focal liver radiotherapy by our department. Individual patient doses based on initial setup positions were calculated by convolving the calculated dose distribution with an anisotropic probability distribution function representing the individual patient's random variations. A separate convolution using population-averaged random variations was performed. Individual beam apertures were then adjusted to provide plans that ensured proper dose to the clinical target volume following convolution with population distributions, as well as individual patient position uncertainty models.
Individual patient setup distributions for the course of treatment had random setup variations (sigma) that ranged from 2.5 to 5.7 mm (left-right), 2.1 to 8.3 mm (anterior-posterior), and 4.1 to 10.8 mm (cranial-caudal). The population random components were 4.2 mm (left-right), 4.1 mm (anterior-posterior), and 7.0 mm (cranial-caudal) at initial setup. The initial static planned dose distribution overestimated the volume of liver irradiated to high doses, because inclusion of setup uncertainties generally blurred the resulting doses, shifting the higher-dose region of normal liver dose-volume histograms to lower doses. Furthermore, the population-based dose convolution tended to predict a higher risk of radiation damage to the liver (based on an in-house parameterization of the Lyman normal tissue complication probability model) than the individual patient calculations. For an individual plan, application of different individual random variations yielded change in effective volume differences with a 3% range. Plan adjustment to account for random setup variations generally resulted in a lower change in effective volume than initial planning using a planning target volume followed by calculation of delivered dose based on random offsets.
This study hints at the factors that most strongly influence planning of liver treatments taking into account geometric variations. Given a setup verification methodology that rapidly reduces systematic offsets, the importance of realistic incorporation of geometric variations as an initial step in treatment planning, as well as possible plan refinement, is demonstrated.
已开发出一种机制,用于评估治疗计划期间随机摆位变化对剂量的影响。随着治疗的推进以及可获得个体患者的摆位测量数据,用于研究这些因素的可用信息从基于人群的模型转向患者特异性数据。本研究评估人群以及患者特异性摆位分布对肝脏局灶性肿瘤治疗计划的影响。
8例肝脏局灶性肿瘤患者按照一项包含在线摆位测量与调整以及呼吸固定的方案进行治疗。这些三维适形治疗的汇总统计数据得出了每个分次初始摆位时的个体和人群位置分布。先前已描述并由本部门研究了一种用于评估随机摆位变化对计算剂量分布影响的卷积模型,以应用于肝脏局灶性放疗。通过将计算出的剂量分布与代表个体患者随机变化的各向异性概率分布函数进行卷积,计算基于初始摆位位置的个体患者剂量。使用人群平均随机变化进行单独的卷积。然后调整各个射野孔径,以提供在与人群分布以及个体患者位置不确定性模型进行卷积后能确保向临床靶体积给予适当剂量的计划。
治疗过程中个体患者的摆位分布具有随机摆位变化(标准差),范围为左右方向2.5至5.7毫米、前后方向2.1至8.3毫米以及头脚方向4.1至10.8毫米。初始摆位时人群随机分量在左右方向为4.2毫米、前后方向为4.1毫米以及头脚方向为7.0毫米。初始静态计划剂量分布高估了接受高剂量照射的肝脏体积,因为纳入摆位不确定性通常会使所得剂量模糊,将正常肝脏剂量体积直方图的高剂量区域向低剂量方向移动。此外,基于人群的剂量卷积倾向于预测肝脏受到辐射损伤的风险更高(基于莱曼正常组织并发症概率模型的内部参数化),高于个体患者计算结果。对于单个计划,应用不同的个体随机变化会使有效体积差异在3%的范围内变化。考虑随机摆位变化进行计划调整通常导致有效体积的变化比使用计划靶体积进行初始计划然后基于随机偏移计算所给予剂量的变化更小。
本研究提示了在考虑几何变化的情况下对肝脏治疗计划影响最强烈的因素。鉴于一种能快速减少系统偏移的摆位验证方法,证明了在治疗计划的初始步骤以及可能的计划优化中切实纳入几何变化的重要性。